Transdiagnostic Versus Diagnosis-specific Cognitive-behavioral Therapy
Transdiagnostic Versus Diagnosis-specific Cognitive-behavioral Therapy for Anxiety Disorders: a Randomized Controlled Pilot Study
Karolinska Institutet
76 participants
Mar 1, 2022
INTERVENTIONAL
Conditions
Summary
The primary aim of the pilot study is to investigate the feasibility of conducting a randomized controlled trial (RCT) comparing the effects of transdiagnostic and diagnosis-specific cognitive-behavioral therapy (CBT) for patients with anxiety disorders in routine psychiatric outpatient care in Stockholm, Sweden. It is hypothesized that an RCT is feasible in terms of recruitment, retention, therapist competence and adherence to treatments, and that the treatments are well received by participants.
Eligibility
Inclusion Criteria4
- years of age,
- Being able to speak Swedish without interpreter support,
- A principal diagnosis of panic disorder, generalized anxiety disorder, social anxiety disorder, obsessive-compulsive disorder, or posttraumatic stress disorder, and
- Pharmacological treatment (if any) that is stable six weeks prior to treatment start
Exclusion Criteria4
- Current diagnosis of psychotic disorder, bipolar disorder, or moderate to severe substance use disorder,
- Moderate to severe risk of suicide,
- Psychiatric, somatic, or social problems which require other management or intervention than cognitive-behavioral therapy, and
- Other simultaneous psychological treatment
Interventions
Transdiagnostic cognitive-behavioral therapy
Diagnosis-specific cognitive-behavioral therapy
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05249543